Teclistamab in R/R MM
Phase I Trial: Updated Analysis of BCMA x CD3 Bispecific Antibody Teclistamab (JNJ-64007957) in Patients With R/R MM

Released: December 08, 2020

Activity

Progress
1
Course Completed